期刊
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
卷 53, 期 3, 页码 241-252出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.critrevonc.2004.10.004
关键词
temozolomide; chemotherapy; schedule
This review examines the current evidence for the use of temozolomide in the treatment of solid tumours. The possible molecular and clinical advantages of temozolomide are identified and the molecular mechanism of temozolomide resistance is explored. Attempts to maximise efficacy have led to manipulation of both dosage and drug scheduling and the evidence for the various strategies is reviewed. Finally, the potential role of combination therapy is considered. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据